RFK Jr. Testifies Before Senate on Health Policy

RFK Jr. faced tough questioning as he caps off seven hearings on the Hill in as many days defending Trump's budget proposal to Congress.

Objective Facts

RFK Jr. faced tough questioning as he caps off seven hearings on the Hill in as many days on April 22, 2026. He took questions from the Senate Finance Committee in the morning and the Senate Committee on Health, Education, Labor, and Pensions in the afternoon. Kennedy was tasked with defending President Donald Trump's proposed 2027 budget, which would boost defense spending while cutting more than 12% of funding from Kennedy's Department of Health and Human Services. While Republicans on the committees praised Kennedy for his agency's investments in rural health and nutrition, exchanges with Democratic senators frequently became rancorous, with Democrats pushing Kennedy to commit to making Trump administration deals with pharmaceutical companies public, grilling him on the measles and other vaccines, and asking him to account for the costs of recent promotional videos from his office. Many Democratic lawmakers have confronted Kennedy about the ways they say his rhetoric and views on vaccines have negatively affected the situation with measles outbreaks.

Left-Leaning Perspective

Democratic senators conducted contentious exchanges with Kennedy, focusing heavily on vaccine policy and drug pricing claims. Sen. Ron Wyden, the top Democrat on the Senate Finance Committee, called on Kennedy to release details about the deals that the Trump administration has inked with more than a dozen drug manufacturers to lower their prices, saying 'The details, the important facts about these deals are totally secret' and 'The only thing that's clear is the list of goodies that the companies got in exchange'. Sen. Elizabeth Warren wanted to know why some of the drugs on TrumpRx cost more than prices available elsewhere, noting that Protonix, a heartburn medication, costs $200 on TrumpRx but it's $16 at Costco. Warren said 'If you're buying a drug on TrumpRX, there is a more than one in four chance that Trump's discount is actually a price hike,' saying it steers patients to more expensive drugs 'that are going to pad Big Pharma's profits'. On vaccines, Democrats pressed Kennedy on his role in measles outbreaks and his refusal to commit to CDC vaccine independence. Rep. Kim Schrier, a Democrat from Washington, argued Kennedy's vaccine views have caused a 'spillover effect' that has led to mothers not giving their babies vitamin K injections common at birth to prevent brain bleeding. Democratic Rep. Raul Ruiz of California asked Kennedy 'If Dr. Schwartz is confirmed, will you commit on the record today to implement whatever vaccine guidance she issues without interference?' and Kennedy said 'I'm not going to make that kind of commitment'. Ranking member Ron Wyden said Kennedy will 'serve up enough fakery this morning to help Senate Republicans ignore the real harm' while 'twisting the truth enough so he can go back to pushing anti-vax policies that make kids sick'. Democratic coverage emphasized the contentious tone and Kennedy's defiance when challenged. When Democrats came out swinging, Kennedy became more defiant, even at times screaming his rebuttals. Democrats framed Kennedy's refusal to release pharmaceutical deals and his equivocation on vaccine guidance as evidence of prioritizing special interests over public health.

Right-Leaning Perspective

Republican senators took divergent approaches to Kennedy, with some offering strong support for his health initiatives while others—particularly physicians—pressed him on specific vaccine policy concerns. Sen. Tim Scott, a Republican from South Carolina, thanked HHS Sec. Robert F. Kennedy Jr. for his help bringing the measles outbreak in his home state under control, saying 'I know without a question we would not be on the right side of this outbreak without your leadership and without your help'. Kennedy listed the work of the agency during his first 15 months leading it, saying it has 'delivered historic wins,' mentioning negotiating drug prices, releasing the new Dietary Guidelines, expanding nutrition education in medical schools, the push to phase out petroleum based food dyes and the Rural Health Transformation Fund. However, some Republican senators raised concerns about vaccine policy. Two top GOP senators who are physicians, John Barrasso (R-Wyoming), grilled Kennedy on vaccines and a key panel focused on preventive screening recommendations during a Senate Finance Committee hearing. Republican Sen. Bill Cassidy of Louisiana said the gap in trust over vaccines has worsened during the past year 'due to false statements about safety and efficacy of vaccines for preventable diseases like measles'. Cassidy also said 'Let's just recognize that if we don't come up with treatments and cures for things like Alzheimer's and dementia and cancer, then the boomer generation could bankrupt our country for the cost of care for these conditions' and 'the way to address that is to invest heavily in science'. Right-leaning coverage generally framed Kennedy's testimony as a strong defense of Trump's health agenda, though acknowledged tensions between Kennedy and some Republican physicians over vaccine policy. The right emphasized Kennedy's accomplishments while largely accepting his explanations on contested issues.

Deep Dive

RFK Jr.'s marathon hearing week reveals the fundamental tension between Kennedy's status as a longtime anti-vaccine activist now leading the nation's health agency and the contradictory demands placed on him. Democrats argue his record directly undermines vaccine confidence during genuine measles outbreaks, while Republicans split between those praising his work on other health initiatives and a small group of physician-senators troubled by his vaccine moves but constrained by party loyalty and political risk. The specific angle of this story—Kennedy's policy defenses on vaccines, budget cuts, and drug pricing—exposes how political calculations override evidence-based health policy across both sides. On vaccines, Kennedy claims global measles increases prove his policies aren't responsible, yet surveys show trust in federal health agencies has continued to decline during Kennedy's tenure. His refusal to commit the CDC director to vaccine guidance independence—the single most direct question asked—suggests his reassurances lack legal teeth. On drug pricing, Kennedy's defense of TrumpRx's "600 percent" reduction claims drew ridicule from mathematicians and Democratic senators, with Kennedy's attempt to justify the figure by suggesting the president calculates percentages through an unconventional method going viral. On HHS cuts, Kennedy cites deficit necessity while Democrats counter that Medicaid enrollment losses will exceed 13 million by 2035. What each side gets right: Democrats correctly identify Kennedy's vaccine history as relevant to assessing his agency's credibility on vaccines, and Republicans rightly note global measles trends complicate attribution. What's omitted: neither side adequately addresses whether vaccine confidence erosion stems from Kennedy's activism, his policy changes, broader pandemic aftereffects, or social media disinformation. Watch whether the Senate confirms Erica Schwartz as CDC director and whether she receives freedom to issue guidance Kennedy opposes—this will clarify whether Kennedy's assurances of independence hold.

OBJ SPEAKING

Create StoryTimelinesVoter ToolsRegional AnalysisAll StoriesCommunity PicksUSWorldPoliticsBusinessHealthEntertainmentTechnologyAbout

RFK Jr. Testifies Before Senate on Health Policy

RFK Jr. faced tough questioning as he caps off seven hearings on the Hill in as many days defending Trump's budget proposal to Congress.

Apr 22, 2026· Updated Apr 23, 2026
What's Going On

RFK Jr. faced tough questioning as he caps off seven hearings on the Hill in as many days on April 22, 2026. He took questions from the Senate Finance Committee in the morning and the Senate Committee on Health, Education, Labor, and Pensions in the afternoon. Kennedy was tasked with defending President Donald Trump's proposed 2027 budget, which would boost defense spending while cutting more than 12% of funding from Kennedy's Department of Health and Human Services. While Republicans on the committees praised Kennedy for his agency's investments in rural health and nutrition, exchanges with Democratic senators frequently became rancorous, with Democrats pushing Kennedy to commit to making Trump administration deals with pharmaceutical companies public, grilling him on the measles and other vaccines, and asking him to account for the costs of recent promotional videos from his office. Many Democratic lawmakers have confronted Kennedy about the ways they say his rhetoric and views on vaccines have negatively affected the situation with measles outbreaks.

Left says: Ranking member Ron Wyden said in his opening statement that he believes Kennedy will 'serve up enough fakery this morning to help Senate Republicans ignore the real harm that's being caused' to the nation's health care system 'while twisting the truth enough so he can go back to pushing anti-vax policies that make kids sick when he's out of the hearing room'.
Right says: While Republicans on the committees praised Kennedy for his agency's investments in rural health and nutrition, though some Republican physicians raised concerns about vaccine policy.
✓ Common Ground
Several voices across the political spectrum acknowledged the need to address measles outbreaks and vaccine-preventable disease transmission, though they disagreed sharply on Kennedy's role in causing them. Sen. Cassidy said 'Any time children are dying from vaccine-preventable diseases [or] we have an increased incidence of reports, whatever the disease is, there should be focus' and 'Speaking as a physician that knows this can be prevented, it grieves me'.
Both Democratic and Republican lawmakers raised concerns about the scope and impact of proposed HHS budget cuts. NIH cuts, in particular, raised bipartisan outcry, with Republican Sen. Thom Tillis of North Carolina saying 'There's an argument to be made that we're handing China our lunch'.
Some Republicans and Democrats shared concern about Kennedy's refusal to commit to CDC director independence on vaccine policy. Democratic Rep. Raul Ruiz asked Kennedy to commit to implement whatever vaccine guidance the CDC director issues without interference, and Kennedy refused, while Republican Sen. Bill Cassidy similarly asked 'Will the new director, whoever she is, have the right to make decisions independently of those political appointees'.
Objective Deep Dive

RFK Jr.'s marathon hearing week reveals the fundamental tension between Kennedy's status as a longtime anti-vaccine activist now leading the nation's health agency and the contradictory demands placed on him. Democrats argue his record directly undermines vaccine confidence during genuine measles outbreaks, while Republicans split between those praising his work on other health initiatives and a small group of physician-senators troubled by his vaccine moves but constrained by party loyalty and political risk. The specific angle of this story—Kennedy's policy defenses on vaccines, budget cuts, and drug pricing—exposes how political calculations override evidence-based health policy across both sides.

On vaccines, Kennedy claims global measles increases prove his policies aren't responsible, yet surveys show trust in federal health agencies has continued to decline during Kennedy's tenure. His refusal to commit the CDC director to vaccine guidance independence—the single most direct question asked—suggests his reassurances lack legal teeth. On drug pricing, Kennedy's defense of TrumpRx's "600 percent" reduction claims drew ridicule from mathematicians and Democratic senators, with Kennedy's attempt to justify the figure by suggesting the president calculates percentages through an unconventional method going viral. On HHS cuts, Kennedy cites deficit necessity while Democrats counter that Medicaid enrollment losses will exceed 13 million by 2035. What each side gets right: Democrats correctly identify Kennedy's vaccine history as relevant to assessing his agency's credibility on vaccines, and Republicans rightly note global measles trends complicate attribution. What's omitted: neither side adequately addresses whether vaccine confidence erosion stems from Kennedy's activism, his policy changes, broader pandemic aftereffects, or social media disinformation. Watch whether the Senate confirms Erica Schwartz as CDC director and whether she receives freedom to issue guidance Kennedy opposes—this will clarify whether Kennedy's assurances of independence hold.

◈ Tone Comparison

Democratic coverage used confrontational language emphasizing deception and corporate favoritism—"fakery," "sweetheart deal for Big Pharma," "fiery exchange"—framing Kennedy as dishonest and corrupt. Republican coverage adopted more neutral or supportive tones, using Kennedy's own language of "historic wins" and "investments," while some Republican physicians employed measured criticism regarding vaccine independence rather than questioning Kennedy's motives.